OR8I4P

Across TCGA pan-cancer cohorts, OR8I4P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated OR8I4P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR8I4P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR8I4P expression acts as an unfavorable survival marker.

STAD and KIRC are the cancer types where OR8I4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.254	0.718	<.001	27	view →
KIRC	OS	Tertile	All	0.138	0.655	.019	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

OR8I4P–STAD (DFS)

Open the STAD breakdown →